Cargando…

Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy

INTRODUCTION: Galactose-deficient IgA1 (Gd-IgA1) is a critical pathogenic factor for IgA nephropathy (IgAN), but its value as a disease-specific biomarker remains controversial. We aimed to clarify the clinical significance of Gd-IgA1 in patients with IgAN. METHODS: We retrospectively reviewed 111 p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wada, Yukihiro, Matsumoto, Kei, Suzuki, Taihei, Saito, Tomohiro, Kanazawa, Nobuhiro, Tachibana, Shohei, Iseri, Ken, Sugiyama, Motonori, Iyoda, Masayuki, Shibata, Takanori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214568/ https://www.ncbi.nlm.nih.gov/pubmed/30388165 http://dx.doi.org/10.1371/journal.pone.0206865

Ejemplares similares

A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Schönlein purpura nephritis and IgA nephropathy
por: Sugiyama, Motonori, et al.
Publicado: (2020)

Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1
por: Ebefors, Kerstin, et al.
Publicado: (2016)

Identification of IgA autoantibodies targeting mesangial cells redefines the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

Clinical significance of IgG deposition in the glomerular mesangial area in patients with IgA nephropathy
por: Wada, Yukihiro, et al.
Publicado: (2012)

Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy
por: Liu, Youxia, et al.
Publicado: (2022)

ELL2 Is Downregulated and Associated with Galactose-Deficient IgA1 in IgA Nephropathy
por: Liu, Youxia, et al.
Publicado: (2019)

Clinical Relevance of Serum Galactose Deficient IgA1 in Patients with IgA Nephropathy
por: Kim, Jin Sug, et al.
Publicado: (2020)

Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy
por: Fukao, Yusuke, et al.
Publicado: (2022)

Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy
por: Placzek, William J., et al.
Publicado: (2018)

Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression
por: Maixnerova, Dita, et al.
Publicado: (2019)

Serum Galactose-Deficient IgA1 Level Is Not Associated with Proteinuria in Children with IgA Nephropathy
por: Hastings, M. Colleen, et al.
Publicado: (2012)

Cellular Signaling and Production of Galactose-Deficient IgA1 in IgA Nephropathy, an Autoimmune Disease
por: Reily, Colin, et al.
Publicado: (2014)

Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy
por: Yasutake, Junichi, et al.
Publicado: (2015)

Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
por: Suzuki, Hitoshi, et al.
Publicado: (2016)

Serial Galactose-Deficient IgA1 Levels in Children with IgA Nephropathy and Healthy Controls
por: Sanders, John T., et al.
Publicado: (2017)

Clinical Significance of Serum Galactose-Deficient IgA1 Level in Children with IgA Nephropathy
por: Irabu, Hitoshi, et al.
Publicado: (2020)

Helicobacter pylori infection is associated with elevated galactose-deficient IgA1 in IgA nephropathy
por: Liu, Xing-Zi, et al.
Publicado: (2020)

Clinical Significance of the Intensity of Glomerular Galactose-Deficient IgA1 Deposition in IgA Nephropathy
por: Nakayama, Maiko, et al.
Publicado: (2022)

cnm-positive Streptococcus mutans is associated with galactose-deficient IgA in patients with IgA nephropathy
por: Misaki, Taro, et al.
Publicado: (2023)

Serum uromodulin is associated with the severity of clinicopathological findings in ANCA-associated glomerulonephritis
por: Tachibana, Shohei, et al.
Publicado: (2019)

Correction: Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression
por: Maixnerova, Dita, et al.
Publicado: (2019)

The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression
por: Zhao, Na, et al.
Publicado: (2012)

Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy
por: Kim, Min Jeong, et al.
Publicado: (2016)

Association of IgG co-deposition with serum levels of galactose-deficient IgA1 in pediatric IgA nephropathy
por: Eison, T. Matthew, et al.
Publicado: (2012)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

Changes in Nephritogenic Serum Galactose-Deficient IgA1 in IgA Nephropathy following Tonsillectomy and Steroid Therapy
por: Nakata, Junichiro, et al.
Publicado: (2014)

Alternative Complement Pathway Is Activated and Associated with Galactose-Deficient IgA(1) Antibody in IgA Nephropathy Patients
por: Chiu, Yen-Ling, et al.
Publicado: (2021)

Phosphatase control of cytokine-mediated overproduction of galactose-deficient IgA1, the main autoantigen in IgA nephropathy
por: Reily, Colin, et al.
Publicado: (2022)

Anti-Phospholipase A2 Receptor (PLA2R) Antibody and Glomerular PLA2R Expression in Japanese Patients with Membranous Nephropathy
por: Hihara, Kei, et al.
Publicado: (2016)

The possible involvement of intestine-derived IgA(1): a case of IgA nephropathy associated with Crohn’s disease
por: Terasaka, Tomohiro, et al.
Publicado: (2016)

Autoantibodies Specific for Galactose-Deficient IgA1 in IgA Vasculitis With Nephritis
por: Suzuki, Hitoshi, et al.
Publicado: (2019)

IgA1 dominant subclass of latent IgA mesangial deposition in donated kidney
por: Oka, Kazumasa, et al.
Publicado: (2016)

IgA Vasculitis and IgA Nephropathy: Same Disease?
por: Pillebout, Evangeline
Publicado: (2021)

Assay for galactose-deficient IgA1 enables mechanistic studies with primary cells from IgA nephropathy patients
por: Reily, Colin, et al.
Publicado: (2018)

Serum levels of galactose-deficient IgA are elevated in patients with IgA nephropathy but do not correlate to disease activity or progression
por: Elíasdóttir, Sigridur, et al.
Publicado: (2023)

Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy
por: Lee, Mingfeng, et al.
Publicado: (2020)

Significance of serum galactose deficient IgA1 as a potential biomarker for IgA nephropathy: A case control study
por: Bagchi, Soumita, et al.
Publicado: (2019)

Diagnostic and prognostic value of galactose-deficient IgA1 in patients with IgA nephropathy: an updated systematic review with meta-analysis
por: Zeng, Qin, et al.
Publicado: (2023)

RhoA vesicle trafficking–mediated transglutaminase 2 membrane translocation promotes IgA1 mesangial deposition in IgA nephropathy
por: Zhong, Zhong, et al.
Publicado: (2023)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8d20jtkdt17dcf1qnt3vi3b7g0